Dense tumor fibrosis can limit checkpoint therapy; a gastrin immunogen combination increases CD8+ infiltration and improves tumor response.
Targeted eIL-31 antigens on virus-like particles induce auto-antibodies to reduce horse pruritus and dermatitis.
This case uses an ε-aminocaproic acid linker and OSK-1 peptide to induce antibodies without traditional protein-carrier antigenicity.
This case uses NKA agonist antibodies or peptide vaccination to protect kidney function and limit PKD complications.
Infusing irradiated allogeneic cells stimulates Th1 immunity to activate innate and adaptive immune mechanisms.
Inducing IgG4 blocking antibodies via HLA antigen administration reduces transplant rejection risk by inhibiting complement fixation and FcR binding.
Antibodies targeting the beta subunit of Na+K+-ATPase inhibit platelet activation, preventing thrombosis without causing bleeding complications.